| |
We are delighted to announce that the Ovarian Club XI Meeting will take place on November 1-3, 2018 in Paris, France.
Following the success of last year’s joint collaboration between the Ovarian Club Meeting (OC) and the Congress on Controversies in Preconception, Preimplantation and Prenatal Genetic Diagnosis (CoGEN), the OC Meeting and CoGEN Congress will take place in concurrently this year as well. Read more >
We look forward to welcoming you in Paris for a new and exciting Ovarian Club experience.
Sincerely yours,
Zeev Shoham
On Behalf of the Ovarian Club XI Organizing Committee
|
|
|
|
|
|
| |
| |
|
EARLY BIRD REGISTRATION
|
|
until September 5, 2018
|
| |
|
| |
|
| |
|
|
|
| |
| |
SCIENTIFIC PROGRAMME
|
| |
|
| |
|
Thursday, November 1, 2018
|
Fertility preservation hands-on workshop
Director: Dror Meirow
Preregistration needed |
| 17:30-19:00 |
Welcome reception |
|
| |
|
Friday, November 2, 2018
|
| 08:30-10:00 |
Session 1: On the forefront of human oocyte biology: aging, bioenergetics, and epigenetics |
| 08:30-09:00 |
Much more than the spindle: a new perspective on cytoplasmic maturation
David Albertini, USA |
| 09:00-09:30 |
Comparative biology of oocyte aging
Pierre Comizzoli, USA |
| 09:30-10:00 |
Testing the potential of in vitro grown oocytes
Helen Picton, UK |
| 10:00-10:30 |
Primordial follicle recruitment and saving ovarian reserve
Sherman Silber, USA |
| 10:30 -11:00 |
Coffee break |
| 11:00-13:00 |
Session 2: Gamete reconstruction |
| 11:00-11:30 |
Drug-free IVA as an infertility treatment for aging poor responders
Kazuhiro Kawamura, Japan |
| 11:30-12:00 |
Genome editing reveals a role for OCT4 in human embryogenesis
Alan Handyside, UK |
| 12:00-12:30 |
Direct gamete differentiation from somatic cells?
Pasqualino Loi, Italy |
| 12:30-13:00 |
Gamete reconstitution in vitro |
| 13:00-14:00 |
Lunch Break |
| 14:00-15:00 |
Session 3: DNA recombination during early embryo development |
| 14:00-14:30 |
Impact of assisted reproduction on genomic imprinting
Mellissa Mann, USA |
| 14:30-15:00 |
Advances in understanding the mechanisms regulating human oocyte activation and growth
Helen Picton, UK |
| 15:00-16:00 |
Session 4: Controlled ovarian hyperstimulation: new drugs, new technologies for whom? |
| 15:00-16:00 |
New forms of drugs: 1. Long-acting FSH, 2. FSH biosimilars and the new recombinant FSH, 3. Progesterone support: I.M., S.C., vaginal and oral
New protocols: 1. Minimal number of injections protocol, 2. Progesterone use to block LH surge. No routine antagonist, 3. Flexibility in starting ovarian stimulation, 4. Double ovarian stimulation
Norbert Gleicher, USA |
| 16:00-16:30 |
Coffee break |
| 16:30-18:00 |
Session 5: Debate: The use of CRISPR/Cas9 technology in human embryos |
| 16:30-17:00 |
Introduction: CRISPR/Cas9
Gerald Schatten, USA |
| 17:00-17:30 |
For: CRISPR/Cas9 |
| 17:30-18:00 |
Ethics: CRISPR/Cas9 and the ban on human germline editing |
|
| |
|
Saturday, November 3, 2018
|
| 08:30-10:30 |
Session 6: Implantation, luteal support and tissue cryopreservation (Part 1) |
| 08:30-09:00 |
How do we choose the best progesterone to support the luteal phase?
Herman Tournaye, Belgium |
| 09:00-09:30 |
Chronic endometritis and endometriosis: how these two combine for altering endometrial receptivity |
| 09:30-10:00 |
Freeze-dry: are we reaching the clinical stage?
Amir Arav, Israel |
| 10:00-10:30 |
Four simple minimum rules to follow for generating a mammalian blastocyst |
| 10:30 -11:00 |
Coffee break |
| 11:00-13:00 |
Session 7: Implantation, luteal support and tissue cryopreservation (Part 2) |
| 11:00-11:30 |
Human immature oocytes can be grown to maturity in vitro: next steps towards clinical application
Evelyn Telfer, UK |
| 11:30-12:00 |
Single center success in freezing ovarian tissue: How we overcome the various obstacles |
| 12:00-12:30 |
A critical review of ovarian tissue freezing
Jacques Donnez, Belgium |
| 12:30-13:00 |
First clinical results of capacitation culture preceding in vitro maturation of human oocytes from small antral follicles in PCOS
Johan Smitz, Belgium |
| 13:00-14:00 |
Lunch break |
| 14:00-16:00 |
Session 8: 40 years of IVF: Best practices with respect to outcome, based on accumulated outcome results |
| 14:00-14:30 |
Managing young women approaching menopause, with high FSH and low AMH
Norbert Gleicher, USA |
| 14:30-16:00 |
Open discussion on:
- Insemination parameters (The minimum number is based on what parameters?)
- DAY 2,3,4,5,6 transfer
- Best embryo culture systems
- Time-lapse vs. timed-static imaging
- When is PGS truly needed and in which cases does PGS clearly improve outcomes?
- All ICSI vs. conventional IVF: why and when?
|
| 16:00-16:30 |
Coffee break |
| 16:30-18:30 |
Session 9: The embryo |
| 16:30-17:00 |
Hormonal regulation of embryo transport
Kenneth Korach, USA |
| 17:00-17:30 |
Nuclear transfer: Clinical applications |
| 17:30-18:00 |
New challenges of mitochondria research in ART
Chii Ruey Tzeng, Taiwan |
| 18:00-18:30 |
Nucleic acids and embryo viability
Samir Hamamah, France |
|
| |
|
| |
| |
|
|
About
Paris
|
|
|
|
|
|
|
|
Meeting
Information
|
|
|
|
|
|
|
|
Scientific
Programme
|
|
|
|
|
|
|
|
| |
| |
|
© 2018 CME-Congresses. All Rights Reserved.
|
|
| |
|
